Molecule Details
| InChIKey | FPZTYKLEJPXTKD-UHFFFAOYSA-N |
|---|---|
| Compound Name | Phenamazoline |
| Canonical SMILES | c1ccc(NCC2=NCCN2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.49 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB19509 |
|---|---|
| Drug Name | Phenamazoline |
| CAS Number | 501-62-2 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Phenamazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Phenamazoline is a antihistaminic or local vasoconstrictor, antazoline derivative. Phenamazoline has a monoisotopic molecular weight of 175.11 Da. |
Cross-references: BindingDB: 50473129 CHEMBL13881 ZINC: ZINC000000001918